The human IVL promoter was used to drive expression of the reverse tetracycline transactivator (rtTA) in the suprabasal layer of the epidermis. Five founders were identified with two highly expressing lines (3 and 4). Line 3 was chosen as the representative line. (J:134564)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count